Smoking and schizophrenia: abnormal nicotinic receptor expression

Citation
S. Leonard et al., Smoking and schizophrenia: abnormal nicotinic receptor expression, EUR J PHARM, 393(1-3), 2000, pp. 237-242
Citations number
73
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
393
Issue
1-3
Year of publication
2000
Pages
237 - 242
Database
ISI
SICI code
0014-2999(20000330)393:1-3<237:SASANR>2.0.ZU;2-1
Abstract
Biological and genetic evidence suggests a role for the neuronal nicotinic receptors in the neuropathophysiology of schizophrenia. Nicotine normalizes an auditory evoked potential deficit seen in subjects who suffer from the disease. Nicotinic receptors with both high and low affinity for nicotine a re decreased in postmortem brain of schizophrenics compared to control subj ects. The chromosomal locus of the human alpha-7 gene (15q14) is linked to the gating deficit with a lod of 5.3, and antagonists of the alpha-7 recept or (alpha-bungarotoxin and methyllycaconitine) induce a loss of gating in r odents. We have cloned the human alpha-7 gene and found it to be partially duplicated proximal to the full-length gene. The duplication is expressed i n both the brain and in peripheral blood cells of normal subjects, but is m issing in some schizophrenic subjects. The results of these studies suggest the presence of abnormal expression and function of the neuronal nicotinic receptor gene family in schizophrenia. (C) 2000 Elsevier Science B.V. All rights reserved.